Factor Va, bound to microparticles released during platelet storage, is resistant to inactivation by activated protein C

Transfusion

Volumn 47, Issue 10, 2007, Pages 1880-1888

  Magdeleyns, Elke J P ^b   Keuren, Jeffrey F W ^b   Curvers, Joyce ^a  

^a CATHARINA HOSPITAL   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5A; THROMBIN; THROMBOCYTE CONCENTRATE;

ARTICLE; BLOOD CLOTTING; CELL ACTIVITY; CONTROLLED STUDY; GEL ELECTROPHORESIS; HUMAN; IMMUNOBLOTTING; NORMAL HUMAN; PHENOTYPE; THROMBIN TIME; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE; THROMBOCYTE PRESERVATION;

ARGININE; BLOOD COAGULATION; BLOOD PLATELETS; BLOOD PRESERVATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FACTOR VA; HEMOSTASIS; HUMANS; PROTEIN C; THROMBOCYTOPENIA; THROMBOPLASTIN;

EID: 34548720409     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01411.x     Document Type: Article

References (34)

1. Lynch SF, Ludlam CA. Plasma microparticles and vascular disorders. Br J Haematol 2007 137 : 36 48.
2. Jy W, Horstman LL, Arce M, Ahn YS. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 1992 119 : 334 45.
3. Springer W, von Ruecker A, Dickerhoff R. Difficulties in determining prophylactic transfusion thresholds of platelets in leukemia patients. Blood 1998 92 : 2183 4.
4. Blajchman MA. Substitutes and alternatives to platelet transfusions in thrombocytopenic patients. J Thromb Haemost 2003 1 : 1637 41.
5. Cauwenberghs S, Feijge MA, Harper AG, Harper AG, Sage SO, Curvers J, Heemskerk JW. Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton. FEBS Lett 2006 580 : 5313 20.
6. Bode AP, Orton SM, Frye MJ, Udis BJ. Vesiculation of platelets during in vitro aging. Blood 1991 77 : 887 95.
7. Keuren JF, Magdeleyns EJ, AB, Bennaghmouch A, Bevers EM, Curvers J, Lindhout T. Microparticles adhere to collagen type I, fibrinogen, Von Willebrand factor and surface immobilised platelets at physiological shear rates. Br J Haematol 2007 in press.
8. Keuren JF, Magdeleyns EJ, Govers-Riemslag JW, Lindhout T, Curvers J. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation. Br J Haematol 2006 134 : 307 13.
9. Hemker HC, van Rijn JL, Rosing J, van Dieijen G, Bevers EM, Zwaal RF. Platelet membrane involvement in blood coagulation. Blood Cells 1983 9 : 303 17.
10. Hayward CP, Fuller N, Zheng S, et al. Human platelets contain forms of factor V in disulfide-linkage with multimerin. Thromb Haemost 2004 92 : 1349 57.
11. Hayward CP, Furmaniak-Kazmierczak E, Cieutat AM, Moore JC, Bainton DF, Nesheim ME, Kelton JG, Côté G. Factor V is complexed with multimerin in resting platelet lysates and colocalizes with multimerin in platelet alpha-granules. J Biol Chem 1995 270 : 19217 24.
12. Gould WR, Silveira JR, Tracy PB. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va. J Biol Chem 2004 279 : 2383 93.
13. Christella M, Thomassen LG, Castoldi E, Tans G, Magdeleyns EJ, Delaunoit C, Debusscher L, Van Assche KJ, Rosing J. Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool. Haematologica 2003 88 : 1150 6.
14. Camire RM, Pollak ES, Kaushansky K, Tracy PB. Secretable human platelet-derived factor V originates from the plasma pool. Blood 1998 92 : 3035 41.
15. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 1994 269 : 31869 80.
16. Nicolaes GA, Tans G, Thomassen MC, Hemker HC, Pabinger I, Varadi K, Schwarz HP, Rosing J. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 1995 270 : 21158 66.
17. Rosing J, Hoekema L, Nicolaes GA, Thomassen MC, Hemker HC, Varadi K, Schwarz HP, Tans G. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 1995 270 : 27852 8.
18. Norstrom E, Thorelli E, Dahlback B. Functional characterization of recombinant FV Hong Kong and FV Cambridge. Blood 2002 100 : 524 30.
19. Briede JJ, Tans G, Willems GM, Hemker HC, Lindhout T. Regulation of factor Va-dependent thrombin generation by activated protein C at the surface of collagen-adherent platelets. J Biol Chem 2001 276 : 7164 8.
20. Camire RM, Kalafatis M, Simioni P, Girolami A, Tracy PB. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C. Blood 1998 91 : 2818 29.
21. Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin JH. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991 77 : 2641 8.
22. Taube J, McWilliam N, Luddington R, Byrne CD, Baglin T. Activated protein C resistance: effect of platelet activation, platelet-derived microparticles, and atherogenic lipoproteins. Blood 1999 93 : 3792 7.
23. Di Scipio RG, Hermodson MA, Davie EW. Activation of human factor X (Stuart factor) by a protease from Russell's viper venom. Biochemistry 1977 16 : 5253 60.
24. Sala N, Owen WG, Collen D. A functional assay of protein C in human plasma. Blood 1984 63 : 671 5.
25. Curvers J, Christella M, Thomassen LG, de Ronde H, Bertina RM, Rosendaal FR, Tans G, Rosing J. Effects of (pre-)analytical variables on activated protein C resistance determined via a thrombin generation-based assay. Thromb Haemost 2002 87 : 483 92.
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 227 : 680 5.
27. Hemker HC, Giesen PL, Ramjee M, Wagenvoord R, Béguin S. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 2000 83 : 589 91.
28. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989 264 : 17049 57.
29. Monkovic DD, Tracy PB. Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. J Biol Chem 1990 265 : 17132 40.
30. Holme PA, Brosstad F. Solum, platelet-derived microvesicles and activated platelets express factor Xa activity. Blood Coagul Fibrinolysis 1995 6 : 302 10.
31. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet JM. Procoagulant microparticles: disrupting the vascular homeostasis equation? Atherioscler Thromb Vasc Biol 2006 26 : 2594 604.
32. Jeimy SB, Woram RA, Fuller N, Quinn-Allen MA, Nicolaes GA, Dahlbäck B, Kane WH, Hayward CP. Identification of the MMRN1 binding region within the C2 domain of human factor V. J Biol Chem 2004 279 : 51466 71.
33. Riddell DR, Vinogradov DV, Stannard AK, Chadwick N, Owen JS. Identification and characterization of LRP8 (apoER2) in human blood platelets. J Lipid Res 1999 40 : 1925 30.
34. Dahlback B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 1994 91 : 1396 400.